Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
A Woburn compounding pharmacy has recalled more than a dozen products it made and distributed since Jan. 1, after an inspection by state and federal regulators found problems with the production process.
Pallimed Pharmacy announced Monday morning that it was voluntarily recalling drugs that were supposed to be produced in a sterile environment, at least half of which are used as injections. The pharmacy will continue making non-sterile products.
“Based on initial results of the inspection, Pallimed agreed to cease and desist all sterile compounding activities and issue the voluntary recall,” the company said in a press release on its website. “Until further notice, Pallimed will not dispense any sterile compound products and will not engage in any sterile compounding activities.”
The recalled products are used for erectile dysfunction, in hormone replacement therapy, and in eye treatments. No illnesses or injuries have been reported as a result of using those the products, according to the statement.